Policy | September 16, 2025
FDA launches crackdown on deceptive drug advertising
The FDA is beginning rulemaking to close the “adequate provision” loophole
The FDA is beginning rulemaking to close the “adequate provision” loophole
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Facility designed to advance the next generation of imaging systems
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
Extended lab space for product development, customer demos, and training
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
Awards highlight Avantor's commitment to the Biopharma industry
Subscribe To Our Newsletter & Stay Updated
